Trials / Sponsors / Mark Stegall
Mark Stegall
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients Kidney Transplant Recipient | Phase 3 | 2022-04-11 |
| Terminated | Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation Disorder of Transplanted Kidney | Phase 2 | 2011-12-01 |
| Completed | Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Trans Kidney Transplant | Phase 1 / Phase 2 | 2008-03-01 |